astragaloside a has been researched along with Autoimmune Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, L; Huang, P; Lan, F; Liu, T; Liu, Y; Lu, X; Luo, X; Yin, H; Yuan, B | 1 |
| Chen, Y; Gan, Y; Hu, Z; Li, M; Li, S; Liu, F; She, T; Xia, H; Yu, L | 1 |
1 trial(s) available for astragaloside a and Autoimmune Diabetes
| Article | Year |
|---|---|
Astragaloside IV attenuates Toll-like receptor 4 expression via NF-κB pathway under high glucose condition in mesenchymal stem cells.
Topics: Animals; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Diabetes Mellitus, Type 1; Drugs, Chinese Herbal; Glucose; Humans; Matrix Metalloproteinase 2; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; RNA, Messenger; Saponins; Toll-Like Receptor 4; Transcription Factor RelA; Triterpenes; Tumor Necrosis Factor-alpha | 2012 |
1 other study(ies) available for astragaloside a and Autoimmune Diabetes
| Article | Year |
|---|---|
Astragaloside IV enhances diabetic wound healing involving upregulation of alternatively activated macrophages.
Topics: Animals; Anti-Inflammatory Agents; Astragalus propinquus; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Extracellular Matrix; Humans; Macrophage Activation; Macrophages; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Saponins; Skin; Triterpenes; Wound Healing | 2016 |